TMS Co., Ltd. (JP:4891) has released an update.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
TMS Co., Ltd., a biopharmaceutical company focusing on transformative medicines, will attend a corporate access event during the J.P. Morgan Annual Healthcare Conference in San Francisco in January 2025. The company is advancing its pipeline which includes treatments for acute ischemic stroke and other serious conditions.
For further insights into JP:4891 stock, check out TipRanks’ Stock Analysis page.